Article
VE1 immunohistochemical detection of the BRAF V600E mutation in thyroid carcinoma: a review of its usefulness and limitations.
Virchows Archiv : an international journal of pathology - 1 Aug 2015
Na Jong-In, Kim Jo-Heon, Kim Hye-Jeong, Kim Hee-Kyung, Moon Kyung-Sub, Lee Ji-Shin, Lee Jae-Hyuk, Lee Kyung-Hwa, Park Jong-Tae
Abstract excerpt
The BRAF V600E mutation is a valuable prognostic factor in thyroid carcinoma despite lingering debate. Successful immunohistochemical (IHC) detection of the BRAF V600E mutation using a VE1 antibody was introduced recently. The objective of this study was to verify the usefulness of IHC detection of the BRAF V600E mutation in thyroid carcinoma using the VE1 antibody. IHC detection of BRAF V600E was performed on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
